425: Strive & Semler Scientific Announce Merger Plans

Strive, Inc. and Semler Scientific, Inc. have announced a proposed business combination, with Strive filing a Form 425 related to the transaction.

Summary

• Strive, Inc. and Semler Scientific, Inc. are pursuing a proposed business combination.
• The filing serves as a cautionary statement regarding forward-looking statements related to the proposed transaction.
• It outlines various risks associated with the merger, including potential delays, integration challenges, and the realization of anticipated benefits.
• Strive intends to file a Registration Statement on Form S-4, which will include an Information Statement/Proxy Statement/Prospectus.
• Stockholders of Semler Scientific will be required to approve the proposed transaction.
• Information regarding participants in the solicitation of proxies, including directors and executive officers of both companies, is provided.

Sentiment

Score: 5

Explanation: The filing is a procedural announcement of a proposed business combination, heavily weighted with cautionary statements regarding forward-looking information and inherent risks. It does not provide specific financial results or a definitive positive/negative outlook, leading to a neutral sentiment.

Positives

• The proposed business combination aims to achieve strategic and financial benefits for the combined entity.
• There is an expectation of successful integration of the combined businesses.

Negatives

• Anticipated benefits, including cost savings and strategic gains, may not be realized as expected or at all.
• Integration of the two companies could be more difficult, time-consuming, or costly than projected.
• The proposed transaction may be more expensive or take longer to complete than anticipated due to unexpected factors.
• Management's attention may be diverted from ongoing business operations and opportunities.
• Potential adverse reactions from customers or changes to business or employee relationships could arise from the announcement or completion of the transaction.
• Changes in Strive's or Semler Scientific's share price may occur before closing.

Risks

• The occurrence of any event, change, or circumstance that could lead to the termination of the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because conditions to closing are not met.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• Anticipated benefits, including cost savings and strategic gains, may not be realized, partly due to risks associated with Bitcoin and other digital assets, general economic conditions, and regulatory changes.
• Integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated.
• Diversion of management's attention from ongoing business operations.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock.
• Potential adverse reactions of customers or changes to business or employee relationships.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other unknown or unpredictable factors could harm the results of Strive, Semler Scientific, or the combined company.

Future Outlook

Expectations for the proposed transaction include strategic and financial benefits, an impact on the combined company's future financial performance, and successful integration. However, these forward-looking statements are subject to significant risks and uncertainties, and actual results may differ materially from anticipated outcomes.

Management Comments

• Matthew Coleman, Chief Executive Officer of Strive, Inc., shared an article on X.com on September 23, 2025, in connection with the proposed business combination with Semler Scientific, Inc.

Industry Context

This announcement reflects a trend of strategic consolidations within various sectors, where companies seek to enhance market position, achieve synergies, or diversify operations. The mention of Bitcoin treasury strategies also places this within the evolving landscape of corporate adoption of digital assets.

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company is listed as a risk factor for the proposed transaction.

Related Party Transactions

• Information about Semler Scientific's transactions with related persons is set forth in its definitive proxy statement in connection with its 2025 Annual Meeting of Stockholders, filed with the SEC on July 17, 2025.

Stakeholder Impact

• Shareholders of Strive may experience dilution due to the issuance of additional Class A common stock.
• Shareholders of Semler Scientific will be required to vote on the proposed transaction.
• Customers and employees of both companies may experience changes to business or employee relationships, potentially leading to adverse reactions.
• Investment professionals and regulatory authorities will need to review the forthcoming detailed filings (e.g., Form S-4) for comprehensive information.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC.
• The Registration Statement will include an Information Statement of Strive, a proxy statement of Semler Scientific, and a prospectus of Strive.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to the stockholders of Semler Scientific.
• Semler Scientific stockholders will be asked to approve the proposed transaction.

Key Dates

Keywords

Strive Inc, Semler Scientific Inc, Merger, Business Combination, SEC Filing, Form 425, Corporate Governance, Risk Management, Financial Reporting, Bitcoin Treasury Strategy, Digital Assets